Medical Care Technologies (OTC PINK:MDCE) Discusses Enterprise-Grade Privacy Architecture for MDCE Melanoma Scan Beta

Rhea-AI Summary

Medical Care Technologies (OTC PINK:MDCE) outlined the privacy-focused architecture for its MDCE Melanoma Scan Beta AI imaging platform. The company is emphasizing secure image handling, user authentication, access controls, data governance, and scalable software design to support future compliance, platform growth, and user confidence.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Company discusses secure image handling, privacy-focused platform architecture, and future compliance-oriented development initiatives

MESA, AZ / ACCESS Newswire / June 16, 2026 / Medical Care Technologies, Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology company focused on artificial intelligence, imaging technologies, and digital wellness platforms, today provided an update on the privacy-focused architecture being incorporated into its MDCE Melanoma Scan Beta platform.

The MDCE Melanoma Scan Beta platform is being developed as an AI-assisted imaging and skin wellness pre-screening technology designed to support skin health through visual monitoring workflows, and preventative wellness awareness initiatives. As development progresses, the Company continues to prioritize secure image handling, user authentication, access management controls, and privacy-focused platform design.

Additional information regarding the MDCE Melanoma Scan Beta platform can be found at https://medicalcaretechnologies.com/.

Medical Care Technologies believes privacy, security, and responsible data stewardship are essential components of next-generation healthcare and wellness technologies. Current development initiatives include evaluating secure image management workflows, data governance practices, and software architecture designed to support long-term platform scalability and future compliance considerations.

"Building trust begins with building the right foundation," stated Marshall Perkins, Chief Executive Officer of Medical Care Technologies. "As we continue developing the MDCE Melanoma Scan Beta platform, we are focused on creating a secure, scalable, and professionally engineered AI imaging platform designed around privacy, security, and responsible software development practices."

The Company believes that establishing privacy-focused infrastructure early in the development lifecycle may help support future platform growth, user confidence, and operational maturity as the platform continues through testing and refinement.

Medical Care Technologies views the MDCE Melanoma Scan Beta platform as an important component of its broader AI imaging strategy and long-term vision involving artificial intelligence, computer vision technologies, preventative wellness applications, and scalable software platforms.

About Medical Care Technologies, Inc.

Medical Care Technologies, Inc. (OTC PINK: MDCE) is a technology company focused on artificial intelligence, imaging technologies, digital wellness platforms, authentication technologies, and advanced software development initiatives. The Company is actively developing AI-assisted imaging and computer vision technologies designed to support emerging opportunities across digital health and preventative wellness markets.

Contact Information

Medical Care Technologies, Inc.
Website: https://medicalcaretechnologies.com/
Email: info@medicalcaretechnologies.com
Phone: 1-480-645-0750
Address: 1910 S Stapley Drive, Suite 221, Mesa, AZ 85204

Safe Harbor Statement

This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding product development, testing activities, future platform capabilities, commercialization opportunities, and business strategy. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

What is the MDCE Melanoma Scan Beta platform from Medical Care Technologies (OTC PINK:MDCE)?

MDCE Melanoma Scan Beta is an AI-assisted imaging and skin wellness pre-screening platform. According to Medical Care Technologies, it is designed to support skin health through visual monitoring workflows and preventative wellness awareness initiatives using computer vision and digital wellness technologies.

How is Medical Care Technologies (MDCE) addressing privacy and security in its Melanoma Scan Beta platform?

Medical Care Technologies is incorporating secure image handling, user authentication, and access management controls. According to Medical Care Technologies, the platform architecture focuses on privacy, security, data governance, and responsible data stewardship to support long-term scalability and future compliance considerations.

Why is privacy-focused infrastructure important for the MDCE Melanoma Scan Beta platform?

The company believes privacy-focused infrastructure can support future platform growth, user confidence, and operational maturity. According to Medical Care Technologies, building privacy and security into early development stages helps establish a strong foundation for testing, refinement, and long-term scaling of the AI imaging platform.

How does the MDCE Melanoma Scan Beta fit into Medical Care Technologies' broader AI imaging strategy?

Medical Care Technologies views MDCE Melanoma Scan Beta as a key part of its wider AI imaging vision. According to Medical Care Technologies, this strategy includes artificial intelligence, computer vision, preventative wellness applications, and scalable software platforms focused on healthcare and digital wellness technologies.

What development initiatives are underway for Medical Care Technologies' (MDCE) Melanoma Scan Beta as of June 16, 2026?

Current initiatives include evaluating secure image management workflows, data governance practices, and scalable software architecture. According to Medical Care Technologies, these efforts aim to align the MDCE Melanoma Scan Beta platform with long-term platform scalability and potential future regulatory and compliance needs.